These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 3740921

  • 1. Minimal change nephrotic syndrome and cyclophosphamide.
    Trompeter RS.
    Arch Dis Child; 1986 Aug; 61(8):727-9. PubMed ID: 3740921
    [No Abstract] [Full Text] [Related]

  • 2. Minimal change nephrotic syndrome.
    Almeida AF, Chafekar DS.
    J Assoc Physicians India; 1993 May; 41(5):257-8. PubMed ID: 8300452
    [No Abstract] [Full Text] [Related]

  • 3. Conventional therapy for idiopathic nephrotic syndrome in children.
    Brodehl J.
    Clin Nephrol; 1991 May; 35 Suppl 1():S8-15. PubMed ID: 1860269
    [Abstract] [Full Text] [Related]

  • 4. [Neurectodermal malignant tumor of the soft tissues after treatment with immunosuppressive agents of lipoid nephrosis].
    Parlier G, Bensman A, Leverger G, Boccon-Gibod L, Gruner M.
    Arch Fr Pediatr; 1992 Feb; 49(2):117-9. PubMed ID: 1374605
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The treatment of minimal change nephrotic syndrome (lipoid nephrosis): cooperative studies of the Arbeitsgemeinschaft für Pädiatrische Nephrologie (APN).
    Brodehl J, Krohn HP, Ehrich JH.
    Klin Padiatr; 1982 Feb; 194(3):162-5. PubMed ID: 6752557
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nephrotic syndrome in childhood. Management and treatment in patients with minimal change disease, mesangial proliferation, or focal glomerulosclerosis.
    McEnery PT, Strife CF.
    Pediatr Clin North Am; 1982 Aug; 29(4):875-94. PubMed ID: 7050865
    [No Abstract] [Full Text] [Related]

  • 15. [Immunosuppressive treatment of glomerulonephritis and nephrotic syndrome].
    Stojimirović B.
    Med Glas; 1971 Aug; 25(7):273-6. PubMed ID: 5148090
    [No Abstract] [Full Text] [Related]

  • 16. Adult-onset minimal-change nephrotic syndrome: a benign disease.
    O'Neill TW, O'Brien AA, Brennan M, Keogh JA.
    Ir J Med Sci; 1987 Sep; 156(9):268-9. PubMed ID: 3679774
    [No Abstract] [Full Text] [Related]

  • 17. Cyclophosphamide in the treatment of idiopathic lipoid nephrosis.
    Etteldorf JN, Roy S, Summitt RL, Sweeney MJ, Wall HP, Berton WM.
    J Pediatr; 1967 May; 70(5):758-66. PubMed ID: 6022179
    [No Abstract] [Full Text] [Related]

  • 18. Letter: Chlorambucil or cyclophosphamide in treatment of nephrosis.
    Berger M, Travis LB, Lorentz WB, Carvajal HF, Smith EH.
    J Pediatr; 1974 Feb; 84(2):310-1. PubMed ID: 4810747
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.